Identification of two subtilisin‐like serine proteases engaged in the degradation of recombinant proteins in Nicotiana benthamiana
Authors:
Open Access
- 1 December 2020
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 595 (3) , 379-388
Abstract
The tobacco variant Nicotiana benthamiana has recently emerged as a versatile host for the manufacturing of protein therapeutics, but the fidelity of many recombinant proteins generated in this system is compromised by inadvertent proteolysis. Previous studies have revealed that the anti‐HIV‐1 antibodies 2F5 and PG9 as well as the protease inhibitor α1‐antitrypsin (A1AT) are particularly susceptible to N. benthamiana proteases. Here, we identify two subtilisin‐like serine proteases (NbSBT1 and NbSBT2) whose combined action is sufficient to account for all major cleavage events observed upon expression of 2F5, PG9 and A1AT in N. benthamiana. We propose that downregulation of NbSBT1 and NbSBT2 activities could constitute a powerful means to optimize the performance of this promising platform for the production of biopharmaceuticals.Databases: NbSBT sequence data are available in the DDBJ/EMBL/GenBank databases under the accession numbers MN534996 to MN535005.Keywords
Funding Information
- Österreichische Forschungsförderungsgesellschaft (822757)
- Austrian Science Fund (W‐1224‐B09)
This publication has 40 references indexed in Scilit:
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMappNature, 2014
- Carbonic anhydrases, EPF2 and a novel protease mediate CO2 control of stomatal developmentNature, 2014
- The human anti‐HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down‐regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant‐based expression platformsBiotechnology Journal, 2014
- Proteolysis of recombinant proteins in bioengineered plant cellsBioengineered, 2013
- Production of Recombinant Antigens and Antibodies in Nicotiana benthamiana Using ‘Magnifection’ Technology: GMP-Compliant Facilities for Small- and Large-Scale Manufacturing2012
- Antibody degradation in tobacco plants: a predominantly apoplastic processBMC Biotechnology, 2011
- Phytaspase, a relocalisable cell death promoting plant protease with caspase specificityThe EMBO Journal, 2010
- Enzymatic assembly of DNA molecules up to several hundred kilobasesNature Methods, 2009
- Generation of glyco‐engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human‐like N‐glycan structurePlant Biotechnology Journal, 2008
- Production and glycosylation of plant‐made pharmaceuticals: the antibodies as a challengePlant Biotechnology Journal, 2004